Skip to content
Intrommune TherapeuticsIntrommune Therapeutics
  • About Us
    • Overview
    • Company Leadership
  • Intrommune R&D
    • Food Allergies
    • Oral Mucosal Immunotherapy
    • INT301 for Peanut Allergy
  • Media
    • Press Releases
    • Events
    • Intrommune in the News
  • Investors
    • Videos
  • White Paper
  • Contact Us
  • Newsletter

    Sign up for Intrommune's newsletter and stay informed of company developments.

    Press Releases


    February 2021

    Intrommune Therapeutics Publishes Peanut Allergy and Immunotherapy Report

    February 2021

    Intrommune Receives IND Clearance From U.S. Food and Drug Administration for INT301

    October 2020

    Intrommune Therapeutics Strikes Deal with Circuit Clinical®

    October 2020

    Recent Peer-Reviewed Publication Supports Immunotherapy for the Treatment of Food Allergies

    September 2020

    Media Alert: Interest in Peanut Allergy Market Heats up in the Wake of Aimmune/Nestlé Deal

    February 2020

    Survey Confirms Physician Interest in Peanut Allergy Immunotherapy

    January 2020

    Intrommune Presenting at Biotech Showcase 2020

    Copyright 2021 © Intrommune Therapeutics. All Rights Reserved.
    Privacy Policy
    • About Us
      • Overview
      • Company Leadership
    • Intrommune R&D
      • Food Allergies
      • Oral Mucosal Immunotherapy
      • INT301 for Peanut Allergy
    • Media
      • Press Releases
      • Events
      • Intrommune in the News
    • Investors
      • Videos
    • White Paper
    • Contact Us
    • Investors

    Login

    Lost your password?